1. The 7-day contraceptive hormone-free interval should be consigned to history
2. Trussell J, Aiken ARA, Guthrie KA. Efficacy, safety and personal considerations. In: Hatcher RA, Nelson AL, Trussel J, Cwiak C, Cason P, Policar MS, Edelman A, Aiken ARA, Marrazzo J, Kowal D, eds. Contraceptive Technology. 21st ed. New York, NY: Ayer Conpany Publishers, Inc.; 2018
3. WHO Family planning and contraception. Available at: https://www.who.int/en/news-room/fact-sheets/detail/family-planning-contraception Accessed March 03, 2020
4. Update on the cost-effectiveness of contraceptives in the United States
5. Palacios S, Wildt L, Parke S, Machlitt A, Römer T, Bitzer J. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A phase III trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2010;149(1):57-62